Artificial Intelligence | Machine Learning | Machine Perception Immunai | Decoding the Immune System to Improve Health

Consumer, Immunology, Healthcare, Biotechnology, Genomic Technologies New York, NY, United States

Immunai

Artificial Intelligence | Machine Learning | Machine Perception

Immunai | Decoding the Immune System to Improve Health

Immunai

Immunology, Healthcare, Biotechnology, Genomic Technologies

New York, NY, United States

Comprehensively mapping the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel discoveries

 
 

   Total Funding: $20,000,000

   Funding Stage: Seed

   Business Stage: Launched

   Market: B2C, B2B

   Company Size: 26 to 50

   Founded: 2019

 
 

AI Startups Funding Deals IntelligenceTry for Free

Date

Round

$ Raised

Investors

10/28/2021

Series B

$215M

8VC, Icon Ventures, Piedmont Capital

Date : 10/28/2021

Round: Series B

$ Raised: $215M

Investors: 8VC, Icon Ventures, Piedmont Capital
 

For AI Startup Founders

Get introduced to VC/PE/CVC investors

Get Started

For Investors at VC/PE firms

Get introduced to AI Startup founders or founders at Immunai

 
 
 
Noam Solomon


Noam Solomon
CEO

Daniel Wells


Daniel Wells
Co-Founder

 
 

Immunai - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups appengine.ai Immunai - Manage Profile

 
 
 
appengine.ai

World's Most Promising AI Startups


Pony.ai
Observe.AI
Kodiak Robotics
OpenAI
Abnormal Security
Groq
Cohere
Anthropic



World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals


Get Started